JOANNE BEATTIE: Open Payments
NPI 1215083621 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,175 in 53 payments from 10 companies in 2025. Trend: 2023 $567 · 2024 $484 · 2025 $1,175
Food & beverage: $1,175
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 26 | $585 |
| Axsome Therapeutics, Inc. | 10 | $275 |
| Vanda Pharmaceuticals Inc. | 4 | $81 |
| Otsuka America Pharmaceutical, Inc. | 3 | $65 |
| Supernus Pharmaceuticals, Inc. | 4 | $65 |
| Alkermes, Inc. | 2 | $32 |
| Collegium Pharmaceutical, Inc. | 1 | $22 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
| Tris Pharma Inc | 1 | $16 |
| Lundbeck LLC | 1 | $15 |
Products named: CAPLYTA, Auvelity, FANAPT, REXULTI, Qelbree, Jornay PM, COBENFY, LYBALVI.
Industry payments across CA — which companies pay providers there.
